4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors

Qing‐Bai She(Memorial Sloan Kettering Cancer Center), Ensar Halilovic(Memorial Sloan Kettering Cancer Center), Qing Ye(Memorial Sloan Kettering Cancer Center), Zhen Wei(Memorial Sloan Kettering Cancer Center), Senji Shirasawa(Fukuoka University), Takehiko Sasazuki(Saitama International Medical Center), David B. Solit(Memorial Sloan Kettering Cancer Center), Neal Rosen(Memorial Sloan Kettering Cancer Center)
Cancer Cell
July 1, 2010
10.1016/j.ccr.2010.05.023
Cited by 400Open Access
Full Text

Abstract

Related Papers

AKT/PKB Signaling: Navigating Downstream
Brendan D. Manning, Lewis C. Cantley|Cell|2007|6.1k
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
Jeffrey A. Engelman, Liang Chen, Xiaohong Tan et al.|Nature Medicine|2008|1.3k
Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function
Arnim Pause, Graham J. Belsham, Anne‐Claude Gingras et al.|Nature|1994|1.2k
RAS/ERK Signaling Promotes Site-specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-dependent Translation
Philippe P. Roux, David Shahbazian, Hieu Vu et al.|Journal of Biological Chemistry|2007|753
Altered Growth of Human Colon Cancer Cell Lines Disrupted at Activated Ki- <i>ras</i>
Senji Shirasawa, Masanori Furuse, Nobuhiko Yokoyama et al.|Science|1993|627